An interventional study of True High-Intensity Focused Electromagnetic Therapy and Sham High-Intensity Focused Electromagnetic Therapy in Patellofemoral Pain Syndrome, sponsored by Middle East University. Not yet recruiting. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-06-08.
Sponsored by Middle East University · Not applicable, Interventional, and Treatment
Evaluate the effect of High-Intensity Focused Electromagnetic Therapy on pain, quadriceps strength, and quality of life in patients with patellofemoral pain syndrome
Patients diagnosed with patellofemoral pain syndrome will be recruited from outpatient physical therapy clinics. Following a comprehensive clinical screening, eligible participants will be randomly assigned into two parallel groups:
The Study Group: Will receive true High-Intensity Focused Electromagnetic Therapy sessions plus a traditional physiotherapy program for 8 weeks.
The Control Group: Will receive sham High-Intensity Focused Electromagnetic Therapy sessions plus the same traditional physiotherapy program for 8 weeks.
297 studies on the registry are indexed under Patellofemoral Pain Syndrome; 74 are open to participants now.
This study's planned enrollment of 60 is above the median of 45 across 244 interventional studies indexed under Patellofemoral Pain Syndrome.
Browse Patellofemoral Pain Syndrome studies →Middle East University is the lead sponsor of 19 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: True High-Intensity Focused Electromagnetic Therapy · Other: Traditional Physiotherapy
Device: Sham High-Intensity Focused Electromagnetic Therapy · Other: Traditional Physiotherapy
20-30 minute sessions, 2-3 times per week for 8 weeks at a clinically effective, tolerable intensity level designed to elicit supramaximal contractions for the quadriceps muscle.
The device protocol, application time, and acoustic feedback will the same as the experimental arm, but with the device in the off state and no muscular contractions in the quadriceps muscle .
Standard rehabilitation program including patellar mobilization with quadriceps and hip abductor strengthening.
Pain level
Visual Analog Scale will be used to assess pain
Time frame: Baseline and after 8 weeks
Quadriceps muscle strength
Isokinetic dynamometry will be used for assessing quadriceps muscle strength
Time frame: Baseline and after 8 weeks
Health-related quality of life
Short Form-12 Health Survey (SF-12) will be used to assess QoL
Time frame: Baseline and after 8 weeks
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jun 2026; primary completion for Oct 2026, 3 months later.
Of 153 non-industry interventional studies with no phase under Patellofemoral Pain Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 20. This study's planned 3 months is below that.
Counting every sponsor, half of 157 studies reached it within 11 months; a quarter within 4 and three quarters within 21.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Patellofemoral Pain Syndrome →
Middle East University